https://wiedzapacjenta.roche.pl2026-01-14https://wiedzapacjenta.roche.pl/pl/trials.html2025-06-06https://wiedzapacjenta.roche.pl/pl/trials/uncategorized.html2019-11-19https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-comparing-atezolizumab--anti-pd-l1-antibody--in-68166.html2025-07-01https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-to-evaluate-the-pharmacokinetics--efficacy--and-safety-o.html2024-10-24https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-to-evaluate-the-efficacy-and-safety-of-atezoliz-39916.html2024-11-06https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-atezolizumab-93464.html2023-06-29https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-0077--75564.html2025-12-02https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-of-the-efficacy-and-safety-of-atezolizumab-plus-chemothe.html2025-09-04https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-evaluating-the-efficacy--safety--and-pharmacoki-19834.html2024-08-30https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--70278.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-04316.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-to-evaluate-efficacy-and-safety-of-giredestrant-50902.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/a-study-of-ro7247669---nab-paclitaxel-compared-with-pem-15706.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/bc/the-purpose-of-this-study-is-to-evaluate-the-efficacy-a-74702.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/leukemia.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/oc.html2020-09-03https://wiedzapacjenta.roche.pl/pl/trials/cancer/crc/a-study-evaluating-the-safety-and-efficacy-of-targeted--57345.html2025-06-06https://wiedzapacjenta.roche.pl/pl/trials/cancer/cca/a-study-of-tiragolumab-plus-atezolizumab-and-atezolizum-32500.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/pv.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/bladder-cancer/a-study-of-atezolizumab-versus-placebo-as-adjuvant-ther-94959.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/bladder-cancer/a-study-of-ro7247669-alone-or-in-combination-with-tirag-35445.html2025-02-07https://wiedzapacjenta.roche.pl/pl/trials/cancer/bladder-cancer/a-study-to-evaluate-the-efficacy-and-safety-of-autogene-25008.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-to-evaluate-efficacy-and-safety-of-multiple-targeted-the.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-to-investigate-the-pharmacokinetics--efficacy---50110.html2025-10-17https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/study-of-atezolizumab-in-combination-with-cabozantinib--77103.html2025-02-28https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-of-atezolizumab-and-tiragolumab-compared-with-d-48756.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-phase-iii--open-label-study-of-maintenance-lurbinecte-08813.html2025-03-13https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-multiple--44971.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-to-evaluate-participant-and-healthcare-professi-70557.html2024-11-22https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-98469.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-evaluating-the-safety--activity--and-pharmacoki-06656.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-to-evaluate-safety--tolerability--pharmacokinet-04290.html2025-03-11https://wiedzapacjenta.roche.pl/pl/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-divarasib-87627.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety-and-efficacy-of-multiple--63288.html2025-02-25https://wiedzapacjenta.roche.pl/pl/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety--pharmacokinetics--and-ac-86713.html2025-03-25https://wiedzapacjenta.roche.pl/pl/trials/cancer/rcc/a-study-of-atezolizumab-in-combination-with-cabozantini-46186.html2025-02-05https://wiedzapacjenta.roche.pl/pl/trials/cancer/rcc/a-study-of-immune-checkpoint-inhibitor-combinations-wit-47221.html2025-03-06https://wiedzapacjenta.roche.pl/pl/trials/cancer/skin-cancer.html2019-07-26https://wiedzapacjenta.roche.pl/pl/trials/cancer/hepatocellular-carcinoma.html2020-06-30https://wiedzapacjenta.roche.pl/pl/trials/cancer/Head_and_Neck_Cancer/a-study-of-ro7121661-and-ro7247669-compared-with-nivolu-07266.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/Brain_Tumor.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/pancreatic-cancer.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/prostate-cancer.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/gc.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/fmi.html2020-06-30https://wiedzapacjenta.roche.pl/pl/trials/cancer/alk-rearranged-non-small-cell-lung-cancer.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/non-hodgkins-lymphoma/a-dose-escalation-study-of-ro7082859-as-a-single-agent-and-in-co.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/cancer/non-hodgkins-lymphoma/a-phase-iii-study-evaluating-glofitamab-in-combination--62070.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-efficacy-and-safety-of-mosunetuz-89423.html2026-01-20https://wiedzapacjenta.roche.pl/pl/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety-and-efficacy-of-glofitam-14259.html2025-02-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/non-hodgkins-lymphoma/an-open-label-study-comparing-glofitamab-and-polatuzuma-51322.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/Hemophilia/a-study-to-evaluate-the-safety--efficacy--pharmacokinet-22898.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/endometrial-cancer/a-study-of-giredestrant-in-participants-with-grade-1-en-08530.html2025-01-23https://wiedzapacjenta.roche.pl/pl/trials/cancer/solid-tumors/a-study-to-evaluate-safety-and-anti-tumor-activity-of-r-73278.html2025-03-06https://wiedzapacjenta.roche.pl/pl/trials/cancer/solid-tumors/tumor-agnostic-precision-immuno-oncology-and-somatic-ta-50851.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/cancer/a-study-of-atezolizumab-with-or-without-bevacizumab-in--17170.html2024-08-31https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/giant-cell-arteritis.html2025-04-15https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/jia.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/ra.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/sjogren-s-syndrome.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/ulcerative-colitis/a-study-to-evaluate-the-efficacy--safety--and-pharmacokinetics-o.html2024-08-31https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/ulcerative-colitis/an-extension-study-to-evaluate-the-long-term-safety-and-37359.html2024-08-31https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/crohn-s-disease.html2025-04-15https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-62318.html2026-03-18https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/sle/a-first-in-human-study-to-investigate-the-safety--toler-46873.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-ro7790121--09855.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-induction--79083.html2025-12-18https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/ln.html2020-02-11https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/neuromyelitis-optica-spectrum-disorders/a-study-to-evaluate-the-safety-and-efficacy-of-satraliz-27030.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/pnh/a-study-evaluating-the-efficacy-and-safety-of-crovalima-16124.html2025-02-12https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/pnh/a-phase-iii-study-evaluating-the-efficacy-and-safety-of-15078.html2025-02-08https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/primary-membranous-nephropathy/a-study-evaluating-the-efficacy-and-safety-of-obinutuzu-42023.html2025-03-25https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/myasthenia-gravis-iab/a-study-to-evaluate-efficacy--safety--pharmacokinetics--13414.html2025-08-01https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/autoimmune-encephalitis/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-99237.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/autoimmune-disorder/mog-antibody-disease/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-94806.html2025-08-26https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/dme/a-study-to-investigate-ro7200220-in-diabetic-macular-ed-90636.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/dme/a-study-to-investigate-ro7200220-in-combination-with-ra-51781.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/glaucoma.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/amd/a-study-to-evaluate-the-long-term-safety-and-tolerabili-60381.html2024-12-12https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/wamd/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-34628.html2024-08-30https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/wamd/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-82370.html2024-09-01https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/wamd/a-study-of-36-week-refill-exchanges-of-port-delivery-sy-66037.html2025-12-01https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/rvo/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-34453.html2024-08-31https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/rvo/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-25491.html2024-08-31https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/uveitic-macular-edema/a-study-to-investigate-ro7200220-in-participants-with-u-27483.html2025-03-26https://wiedzapacjenta.roche.pl/pl/trials/eye-disorder/myopia/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-11547.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/muscle-and-peripheral-nerve-disease/sma/a-study-of-risdiplam-in-infants-with-genetically-diagno-31840.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/muscle-and-peripheral-nerve-disease/sma/a-study-to-investigate-the-safety-and-efficacy-of-ro720-92328.html2025-03-25https://wiedzapacjenta.roche.pl/pl/trials/muscle-and-peripheral-nerve-disease/dmd/an-open-label-study-to-assess-the-efficacy-and-safety-o-12382.html2025-04-22https://wiedzapacjenta.roche.pl/pl/trials/muscle-and-peripheral-nerve-disease/muscular-dystrophy.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/infectious-diseases/influenza/study-to-assess-the-safety--pharmacokinetics--and-effic-62594.html2024-06-22https://wiedzapacjenta.roche.pl/pl/trials/infectious-diseases/influenza/study-to-assess-the-efficacy-of-baloxavir-marboxil-vers-02272.html2025-02-05https://wiedzapacjenta.roche.pl/pl/trials/infectious-diseases/influenza/a-surveillance-study-of-susceptibility-to-baloxavir-mar-15550.html2025-02-19https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety-and-tolerability-of-long-88018.html2026-01-27https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-pharmacodynamic--pd--effects-of-20860.html2024-08-31https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-efficacy-and-safety-of-gantener-84528.html2024-08-30https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety-and-biomarker-effects-of-20108.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/screening-study-to-determine-individuals-with-potential-76396.html2025-10-21https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/a-clinical-trial-of-trontinemab-in-participants-with-ea-85398.html2026-02-16https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/ad/a-study-of-trontinemab-in-participants-with-early-sympt-02194.html2026-02-16https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/als.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/pd/a-study-to-evaluate-the-efficacy-and-safety-of-intraven-35605.html2025-01-22https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/multiple-sclerosis/study-to-evaluate-the-effectiveness-and-safety-of-ocrelizumab-in.html2025-01-16https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-of-ocrelizumab-in-children-and-adolescents-with-52808.html2025-03-27https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy-and-safety-of-ocrelizu-22490.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/multiple-sclerosis/a-study-of-ocrelizumab-in-participants-with-primary-pro-36628.htmlhttps://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/hd/a-study-to-evaluate-the-safety--biomarkers--and-efficac-41200.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/neurodegenerative-disorder/hd/frequency-of-selected-single-nucleotide-polymorphisms-i-91631.html2025-10-21https://wiedzapacjenta.roche.pl/pl/trials/neurodevelopmental-disorder/autism-spectrum-disorder.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/psychiatric-disorder.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/psychiatric-disorder/schizophrenia.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/psychiatric-disorder/schizophrenia/a-study-to-assess-the-effects-of-ro6889450-in-participa-51328.htmlhttps://wiedzapacjenta.roche.pl/pl/trials/respiratory-disorder.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/healthy-volunteers.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/kidney-disorder/iga-nephropathy/a-study-to-evaluate-the-efficacy-and-safety-of-ro743465-06097.html2025-06-24https://wiedzapacjenta.roche.pl/pl/trials/metabolic-disorder/dr/a-study-to-investigate-the-efficacy-and-safety-of-rg777-36226.html2024-09-26https://wiedzapacjenta.roche.pl/pl/trials/hematologic-diseases/a-study-evaluating-the-efficacy--safety--pharmacokineti-29406.html2025-05-19https://wiedzapacjenta.roche.pl/pl/trials/hematologic-diseases/myelodysplastic-syndrome.html2018-12-20https://wiedzapacjenta.roche.pl/pl/trials/hematologic-diseases/Hemophilia.html2023-05-10https://wiedzapacjenta.roche.pl/pl/trials/Hemophilia/hemophilia-a/a-study-to-evaluate-the-safety--tolerability--pharmacok-88545.html2025-01-15https://wiedzapacjenta.roche.pl/pl/faq.html2020-08-06https://wiedzapacjenta.roche.pl/pl/faq/what-is-a-clinical-trial.html2023-05-09https://wiedzapacjenta.roche.pl/pl/faq/why-should-i-consider-taking-part-in-a-clinical-trial.html2020-08-06https://wiedzapacjenta.roche.pl/pl/faq/roche-in-clinical-trials.html2023-05-09https://wiedzapacjenta.roche.pl/pl/error.html2018-11-21https://wiedzapacjenta.roche.pl/pl/error/404.html2024-10-18https://wiedzapacjenta.roche.pl/pl/error/403.html2024-10-18https://wiedzapacjenta.roche.pl/pl/error/500.html2024-10-18https://wiedzapacjenta.roche.pl/pl/privacy-policy.html2018-11-21https://wiedzapacjenta.roche.pl/pl/glossary-terms.html2020-09-01https://wiedzapacjenta.roche.pl/pl/About.html2019-02-14https://wiedzapacjenta.roche.pl/pl/sitemap.html2018-11-21https://wiedzapacjenta.roche.pl/pl/disease-area-overview.html2020-08-07https://wiedzapacjenta.roche.pl/pl/new-solr-search.html2024-02-16